AAAAAA

   
Results: 1-8 |
Results: 8
Nonpeptidic, monocharged, cell permeable ligands for the p56lck SH2 domain
Authors: Proudfoot, JR Betageri, R Cardozo, M Gilmore, TA Glynn, S Hickey, ER Jakes, S Kabcenell, A Kirrane, TM Tibolla, AK Lukas, S Patel, UR Sharma, R Yazdanian, M Moss, N Beaulieu, PL Cameron, DR Ferland, JM Gauthier, J Gillard, J Gorys, V Poirier, M Rancourt, J Wernic, D Llinas-Brunet, M
Citation: Jr. Proudfoot et al., Nonpeptidic, monocharged, cell permeable ligands for the p56lck SH2 domain, J MED CHEM, 44(15), 2001, pp. 2421-2431
Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: Towards smaller inhibitors
Authors: Llinas-Brunet, M Bailey, M Fazal, G Ghiro, E Gorys, V Goulet, S Halmos, T Maurice, R Poirier, M Poupart, MA Rancourt, J Thibeault, D Wernic, D Lamarre, D
Citation: M. Llinas-brunet et al., Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: Towards smaller inhibitors, BIOORG MED, 10(20), 2000, pp. 2267-2270
'Homogenese'
Authors: Rancourt, J
Citation: J. Rancourt, 'Homogenese', LIBERTE, 42(4), 2000, pp. 84-85
Le 'Stylo Rouge'
Authors: Rancourt, J
Citation: J. Rancourt, Le 'Stylo Rouge', LIBERTE, 42(4), 2000, pp. 85-87
La 'Matiere Claire'
Authors: Rancourt, J
Citation: J. Rancourt, La 'Matiere Claire', LIBERTE, 42(4), 2000, pp. 88-89
Use of intravenous gamma-globulin in the treatment of neutropenia in humanimmunodeficiency virus infection
Authors: Okechukwu, CN Ross, J Rancourt, J
Citation: Cn. Okechukwu et al., Use of intravenous gamma-globulin in the treatment of neutropenia in humanimmunodeficiency virus infection, INF DIS C P, 8(6), 1999, pp. 314-316
Phosphotyrosine-containing dipeptides as high-affinity ligands for the p56(lck) SH2 domain
Authors: Llinas-Brunet, M Beaulieu, PL Cameron, DR Ferland, JM Gauthier, J Ghiro, E Gillard, J Gorys, V Poirier, M Rancourt, J Wernic, D
Citation: M. Llinas-brunet et al., Phosphotyrosine-containing dipeptides as high-affinity ligands for the p56(lck) SH2 domain, J MED CHEM, 42(4), 1999, pp. 722-729
Ligands for the tyrosine kinase p56(lck) SH2 domain: Discovery of potent dipeptide derivatives with monocharged, nonhydrolyzable phosphate replacements
Authors: Beaulieu, PL Cameron, DR Ferland, JM Gauthier, J Ghiro, E Gillard, J Gorys, V Poirier, M Rancourt, J Wernic, D Llinas-Brunet, M Betageri, R Cardozo, M Hickey, ER Ingraham, R Jakes, S Kabcenell, A Kirrane, T Lukas, S Patel, U Proudfoot, J Sharma, R Tong, L Moss, N
Citation: Pl. Beaulieu et al., Ligands for the tyrosine kinase p56(lck) SH2 domain: Discovery of potent dipeptide derivatives with monocharged, nonhydrolyzable phosphate replacements, J MED CHEM, 42(10), 1999, pp. 1757-1766
Risultati: 1-8 |